![2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide](https://static.cymitquimica.com/products/3D/img/FM43025.png "Clique para ampliar")
2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide
CAS: 511296-88-1
Ref. 3D-FM43025
| 1g | Descontinuado | ||
| 2g | Descontinuado | ||
| 5g | Descontinuado | ||
| 10g | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide
Descrição:
2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide is a novel agent that has been shown to be effective in the treatment of non-small cell lung cancer. The mechanism of action involves inhibition of sirtuin (SIRT) enzymes and consequent induction of apoptosis in cancer cells. The drug also inhibits the production of mononucleotides that are essential for DNA synthesis and RNA transcription. 2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide has been tested in clinical trials for the treatment of depression. This drug has also been shown to have muscle strengthening effects by increasing levels of creatine kinase and insulin like growth factor 1 (IGF-
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
349.29 g/mol
Fórmula:
C16H17BrN2S
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
